The Sylvia Lawler meeting is the prestigious annual prize meeting for the RSM Oncology Section and was established in memory of Sylvia Lawler one of this country's first female geneticists. The meeting provides a forum for clinicians and scientists in training to present their research.

Following her MRes in Translational Cancer Medicine at KCL (2016-2017), Beth joined the TOUR team to conduct a PhD on “Clinical outcomes for bladder cancer”. Using data from the Swedish National BladderBase dataset, her first project focuses on the effect of neoadjuvant chemotherapy on bladder cancer survival following a radical cystectomy. The work is highly clinically relevant and was hence selected for the RSM meeting.

Gincy George joined the TOUR team in January 2017 after having worked there for two years as a clinical trials coordinator. Her PhD focuses on the use of androgen deprivation therapy (ADT) for advanced prostate cancer. The work Gincy presented compared the risk of cardiovascular disease following ADT initiation between a recently introduced ADT (Gonadotropin-releasing hormone antagonists) and the commonly used GnRH agonists. This is the first study of its kind using data from Belgium, the Netherlands, France, and the UK. Following her poster presentation, Gincy was awarded with the best poster prize in clinical oncology.

On her award, Gincy said:

"It is truly an honour to win the prestigious Sylvia Lawler prize for best clinical poster presentation established in memory of one of this country's first female geneticists”.